Abstract
<br>A 65-year-old man with recurrent vitreous hemorrhage, after vitrectomy for proliferative diabetic retinopathy (PDR), was referred to us for further management. He was treated with an intravitreal anti-vascular endothelial growth factor (anti-VEGF) injection. Six weeks after the injection, the hemorrhage cleared. At this stage, multimodal imaging including fundus fluorescein angiography (FFA) and swept-source optical coherence tomography angiography (SS-OCTA) was done to determine the source of the vitreous hemorrhage. Surprisingly, while there was no leakage on FFA, the neovascularization (NV) was beautifully captured on SS-OCTA.<br>
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
